Guggenheim Trims NextGen Healthcare (NASDAQ:NXGN) Target Price to $22.00

NextGen Healthcare (NASDAQ:NXGNGet Rating) had its price objective decreased by Guggenheim from $26.00 to $22.00 in a research report released on Tuesday morning, The Fly reports.

NXGN has been the subject of several other research reports. StockNews.com assumed coverage on shares of NextGen Healthcare in a research note on Thursday, May 18th. They issued a buy rating for the company. TheStreet downgraded shares of NextGen Healthcare from a b- rating to a c rating in a research note on Tuesday, May 16th. Piper Sandler decreased their price target on shares of NextGen Healthcare from $20.00 to $17.00 in a research note on Thursday, May 18th. Stephens began coverage on shares of NextGen Healthcare in a research note on Tuesday, April 11th. They issued an overweight rating and a $24.00 price target for the company. Finally, Truist Financial decreased their price target on shares of NextGen Healthcare from $22.00 to $18.00 in a research note on Monday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average price target of $21.20.

NextGen Healthcare Trading Down 1.2 %

NASDAQ NXGN opened at $15.45 on Tuesday. The firm has a 50 day simple moving average of $16.98 and a 200-day simple moving average of $18.15. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.53 and a current ratio of 2.03. NextGen Healthcare has a one year low of $15.23 and a one year high of $21.99. The firm has a market cap of $1.02 billion, a price-to-earnings ratio of -386.25 and a beta of 1.04.

Institutional Trading of NextGen Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NXGN. American Century Companies Inc. raised its holdings in NextGen Healthcare by 2.1% during the first quarter. American Century Companies Inc. now owns 50,366 shares of the company’s stock worth $1,053,000 after purchasing an additional 1,031 shares in the last quarter. Natixis Advisors L.P. acquired a new stake in NextGen Healthcare during the first quarter worth approximately $280,000. MetLife Investment Management LLC raised its holdings in NextGen Healthcare by 49.4% during the first quarter. MetLife Investment Management LLC now owns 32,724 shares of the company’s stock worth $684,000 after purchasing an additional 10,823 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in NextGen Healthcare by 11.5% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 48,421 shares of the company’s stock worth $1,012,000 after purchasing an additional 5,004 shares in the last quarter. Finally, APG Asset Management N.V. acquired a new stake in NextGen Healthcare during the first quarter worth approximately $958,000. Institutional investors and hedge funds own 73.70% of the company’s stock.

About NextGen Healthcare

(Get Rating)

NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.

Featured Stories

The Fly logo

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.